I wouldn't. But Mr. Saunders -- acting as a steward for Forest Labs -- just did. Why? Because Forest's other schizophrenia drug candidate recently clanked -- at FDA. [And, less charitably, because he is still in the thrall of one Fast Fred Hassan, as to asenapine.]
Sadly, I think he must still be at least sipping, if not gulping Fred Hassan's Kool Aid®. First at Schering, then at B+L, and now at Forest. Mr. Saunders has most recently cut heads, levered up/issued debt, and amped up a stock buyback. . . and now overpaid for a long since faded comet. In my opinion, Saphris® is now (mostly) a dark, dingy, icy ball of known and documented side effects -- with a dubious efficacy profile, compared to its peers.
But like Fast Fred, Brent must think if his US sales force flogs it hard enough -- to psychiatrists treating institutionalized patients here, he will reverse the declines Whitehouse Station has seen. Me? I'd not bet on Forest being able to out-detail the legendary sales forces Merck had assembled. But that's what makes it fun to watch. I'll go pop some popcorn -- sit tight! [Maybe Mr. Saunders, and Forest, will agree to take over the Merck dedicated sales people, too. We will see. And we will hope -- but we doubt it. He (like Fred, before him!) always thinks his are the only smart people in the room.]
2 comments:
Don't know if this went through the first time. I was experiencing technical difficutlties~~
So, what do you think? Is Brent following in Fast Freddie's playbook?
http://www.pmlive.com/pharma_news/az_said_to_be_eyeing_forest_takeover_bid_523899
Ooh -- hadn't seen that -- but yet, it looks quite a bit like it!
Some apples don't fall very far from the tree, right?
When the five day hiatus for Mr. President Mandela is over, I'll blog it. . . thank you so much.
Do stop back!
Great find!
Namaste
Post a Comment